A recent paper by Kotaro Suzuki, Postdoctoral Research Fellow at Vancouver Prostate Centre of the University of British Columbia, published in International Journal of Clinical Oncology, was mentioned by Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, on X:

“Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients showed reduction of IVC thrombus level in 47.8% of patients, reduced OR time, EBL mean (3170 mL vs. 1167 mL; p = 0.004) and need for extracorporeal circulation (all Level IV), grade ≥ III perioperative complications (11% vs 0).”

“Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombus”

Authors: Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto hara, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Akihisa Yao, Jun Teishima, Hideaki Miyake.

Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.

More posts featuring Laura Bukavina.